Genzyme, Daiichi allow Impax to launch a generic Welchol

06/30/2011 | Reuters

Generic-drug maker Impax Laboratories resolved a patent dispute with Genzyme and Daiichi Sankyo regarding diabetes pill Welchol. The settlement allows Impax to market its version on March 2, 2015, or earlier under certain conditions.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President, Science and Regulatory Affairs
American Beverage Association
Washington, DC
Senior Manager of Medical Management
Network Health
Medford, MA
MEDICAL SCIENCE LIAISON - 14000002RO
Abbott
Columbus, OH
Manager, Medical Management
Network Health
Medford, MA
Executive Medical Director
Aspirus Network Inc
Wausau, WI